MENU
APR 22, 2019 12:00 AM PDT

Direct Oral Anti-Coagulant (DOAC) Measurement Focusing on Anti-Xa, and Recent DOAC Trial Updates

Sponsored by: Diagnostica Stago, Inc.
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Chair and Professor, Medicine (primary) Professor, Clinical Epidemiology and Biostatistics (Associate) Leo Pharma Chair in Thromboembolism Research
    Biography
      Dr Crowther's research interests include improving the way we use current anticoagulant drugs. These include exploring established and novel interventions to mitigate bleeding, and studies of currently available anticoagulant drugs in high-risk patient populations. Dr Crowther's work also focusses on developing systematic reviews of key questions in Hematology and Thrombosis, and basing Guidelines on those reviews.

      Dr Crowther has more than 400 peer reviewed publications, was inducted into the Royal Society of Canada in 2017, and received the 2017 International Society of Thrombosis and Haemostasis BACH Investigator Recognition Award. He was one of 14 scientists from the Michael G. DeGroote School of Medicine at McMaster University cited by Clarivate Analytics on its Highly Cited Researchers list (formerly known as Thomson Reuter's annual publication of The World's Most Influential Scientific Minds).

      Dr Crowther is currently the Chair, Department of Medicine at McMaster University and holds the Leo Pharma Chair in Thromboembolism Research at McMaster University.

    Abstract

    Have you ever wondered about the impact of direct oral anticoagulants (DOACs) on routine coagulation assays and how patients on DOACs can be managed by the clinical laboratory? DOACs have been available for several years to treat atrial fibrillation patients at risk of stroke, as well as patients with venous thromboembolism (VTE). Though routine monitoring is not required for patients taking DOACs, screening or measurement assays could help in some emergency patient management situations. Dr Crowther’s webinar will cover this hot topic, which regularly impacts patients in critical care settings.

    Learning objectives:

    • Highlight recent clinical trials describing use of DOACs
    • Present situations for which DOAC monitoring can help in the picture of patient care
    • Review best practice with respect to DOAC measurement

     

    LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.  CE credits are available for this webinar up to 2 years from the date of the live broadcast


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    DEC 15, 2020 10:00 AM PST
    C.E. CREDITS
    DEC 15, 2020 10:00 AM PST
    DATE: December 15, 2020 TIME: 10:00am PST Scientists from Thermo Fisher Scientific will walk us through the world of microorganisms. They will discuss their most recent research on viruses,...
    DEC 09, 2020 9:00 AM PST
    C.E. CREDITS
    DEC 09, 2020 9:00 AM PST
    DATE: December 09, 2020 TIME: 09:00am PST Hematopoietic stem cells (HSCs) ensure homeostasis of blood throughout life. In this webinar, we share insights into the smart and easy isolation, c...
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    SEP 03, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 03, 2020 9:00 AM PDT
    DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
    APR 22, 2019 12:00 AM PDT

    Direct Oral Anti-Coagulant (DOAC) Measurement Focusing on Anti-Xa, and Recent DOAC Trial Updates

    Sponsored by: Diagnostica Stago, Inc.
    C.E. Credits: P.A.C.E. CE Florida CE

    Specialty

    Laboratory Testing

    Hematology

    Clinical Diagnostics

    Clinical Chemistry

    Immunology

    Microbiology

    Infectious Disease

    Molecular Diagnostics

    Molecular Biology

    Diagnostics

    Biochemistry

    Medicine

    Chemistry

    Cancer Diagnostics

    Clinical Research

    Geography

    North America82%

    Europe7%

    Asia6%

    South America3%

    Oceania1%

    Africa1%

    Registration Source

    Website Visitors66%

    Email Promotions21%

    WAVE Newsletter Promotion10%

    Trending Newsletter Promotion2%

    Other1%

    Job Title

    Medical Laboratory Technician31%

    Clinical Laboratory Scientist22%

    Lab Management13%

    Facility/Department Manager8%

    Medical Doctor/Specialist8%

    Educator/Faculty4%

    Executive4%

    Student4%

    QC/QA1%

    Pathologist1%

    Pharmacist1%

    Research Scientist1%

    Scientist1%

    Organization

    Hospital49%

    Clinical Laboratory16%

    Academic Institution9%

    Medical Center4%

    Diagnostic Company2%

    Medical School2%

    Medical Device Company2%

    Government2%

    Ambulatory Care2%

    Physician Office Laboratory1%

    Biotech Company1%

    Independent Laboratories1%

    Research Institute1%

    Consultant1%

    Other2%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more